Intermediate-risk thyroid carcinoma: indicators of a poor prognosis

Intermediate-risk thyroid carcinoma: indicators of a poor prognosis

ABSTRACT Objective: The intermediate-risk (IR) category includes tumors with different degrees of aggression. We aimed to identify the risk factors associated with unfavorable response to initial treatment and compare the effect of low/high radioactive iodine (RAI) therapy. Subjects and methods: A...

Full description

Bibliographic Details
Main Authors:	Fernanda Nascimento Faro, Ângela Maria Leal Barros Bezerra, Nilza Maria Scalissi, Adriano Namo Cury, Marília Martins Marone, Carolina Ferraz, Rosália do Prado Padovani
Format:	Article
Language:	English
Published:	Brazilian Society of Endocrinology and Metabolism 2020-08-01
Series:	Archives of Endocrinology and Metabolism
Subjects:	Thyroid neoplasms thyroid cancer differentiated thyroid cancer radioactive iodine therapy thyroglobulin prognosis
Online Access:	http://www.scielo.br/scielo.php?script=sci_arttext&pid=S2359-39972020000600764&tlng=en

Similar Items

Predictive Role of Serum Thyroglobulin after Surgery and before Radioactive Iodine Therapy in Patients with Thyroid Carcinoma
by: Alberto Signore, et al.
Published: (2023-05-01)

Comparing the efficacy of thyroglobulin and thyroglobulin/ thyroid-stimulating hormone ratio models in predicting a successful response to radioactive iodine therapy
by: Yanli Ju, et al.
Published: (2023-01-01)

Effect of therapeutic radioiodine activity on ablation response in differentiated thyroid cancer patients with cut-off serum thyroglobulin levels after 2 weeks of thyroid hormone withdrawal: a retrospective study
by: Ji Young Lee, et al.
Published: (2022-12-01)

The clinical meaning of pre- and post-ablation thyroglobulin levels at first radioiodine therapy in patients with papillary thyroid cancer
by: Hee Kyung Kim, et al.
Published: (2020-09-01)

Impact of thyroiditis on 131I uptake during ablative therapy for differentiated thyroid cancer
by: Eugenie S Lim, et al.
Published: (2019-05-01)

Analysis of tumor recurrence factors of the patients with intermediate risk papillary thyroid carcinoma after radioactive iodine treatment
by: TANG Linglin, LI Li, LAI Yi, LIU Jianjun, ZHOU Xiang
Published: (2023-11-01)

Efficacy of Empirical Radioiodine Therapy in Patients with Differentiated Thyroid Cancer and Elevated Serum Thyroglobulin without Evidence of Structural Disease: A Propensity Score Analysis
by: Leandra Piscopo, et al.
Published: (2023-08-01)

Iodine Status and Thyroid Function in Lactating Women and Infants – a Survey in the Zagreb Area, Croatia
by: Marina Prpić, et al.
Published: (2021-01-01)

Poorly differentiated papillary thyroid carcinoma in a 5-year-old girl: a case report
by: Mohanned Mohsen, et al.
Published: (2024-02-01)

Predictors of thyroglobulin in the lymph nodes recurrence of papillary thyroid carcinoma undergoing total thyroidectomy
by: Zhichao Xing, et al.
Published: (2021-01-01)

Clinical features of bone metastasis for differentiated thyroid carcinoma: A study of 21 patients from a Tunisian center
by: Faouzi Kallel, et al.
Published: (2014-01-01)

A cutoff thyroglobulin value suggestive of distant metastases in differentiated thyroid cancer patients
by: J.S. Couto, et al.
Published: (2020-10-01)

A case of the accumulation of 131-iodine in the mammary gland after remnant ablation for papillary thyroid carcinoma on lactating period
by: Daisuke Murayama, MD, et al.
Published: (2021-11-01)

Long-Term Survival Analysis and Prognostic Factors of Arabic Patients with Differentiated Thyroid Carcinoma: A 20-Year Observational Study at the King Hussein Cancer Center (KHCC) Involving 528 Patients
by: Akram Al-Ibraheem, et al.
Published: (2023-08-01)

High prevalence of iodine deficiency in pregnant women living in adequate iodine area
by: Verônica Carneiro Borges Mioto, et al.
Published: (2018-05-01)

Coexistence of Hashimoto’s Thyroiditis in Differentiated Thyroid Cancer: Post-Operative Monitoring of Anti-Thyroglobulin Antibodies and Assessment of Treatment Response
by: Alessandra Donnici, et al.
Published: (2024-01-01)

Prognostic factors for incomplete response in thyroid microcarcinoma: an analysis of initial response to therapy in 517 patients
by: Fernanda Nascimento Faro, et al.
Published: (2021-03-01)

Differentiated Thyroid Carcinoma and Late Onset of Lung Distant Metastasis. A Case Report
by: Alessandro Semprebene, et al.
Published: (2019-02-01)

A Multiplex Thyroid-Specific Assay for Quantification of Circulating Thyroid Cell-Free RNA in Plasma of Thyroid Cancer Patients
by: Samantha Peiling Yang, et al.
Published: (2021-08-01)

Global scientific trends on thyroid disease in early 21st century: a bibliometric and visualized analysis
by: Mingyuan Song, et al.
Published: (2024-01-01)

The diagnostic and predictive accuracy of thyroglobulin to TSH ratio and TSH to thyroglobulin ratio in detecting differentiated thyroid carcinoma in normothyroid patients with thyroid nodules: A retrospective cohort study and systematic review of the literature
by: Evangelos Karvounis, et al.
Published: (2021-01-01)

Tyrosine Kinase Inhibitors for Radioactive Iodine Refractory Differentiated Thyroid Cancer
by: Christos Cortas, et al.
Published: (2023-12-01)

Radioactive iodine-refractory differentiated thyroid cancer: an uncommon but challenging situation
by: Angelica Schmidt, et al.
Published: (2017-02-01)

Rare Clinical Entity: Metastatic malignant struma ovarii diagnosed during pregnancy – Lessons for management
by: Corey J. Lager, et al.
Published: (2018-06-01)

The Prognostic Role of Postablative Non-Stimulated Thyroglobulin in Differentiated Thyroid Cancer
by: Szabina Szujo, et al.
Published: (2021-01-01)

Lithium therapy: an unusual cause of elevated and diffuse radioactive iodine uptake.
by: Ebenezer A Nyenwe, et al.
Published: (2008-10-01)

Modern therapy of radioactive iodine-refractory differentiated thyroid cancer: resolution of the Expert Council
by: P O Rumyantsev, et al.
Published: (2016-09-01)

Risk and outcome of subsequent malignancies after radioactive iodine treatment in differentiated thyroid cancer patients
by: Xiaoran Mei, et al.
Published: (2021-05-01)

Radioactive Iodine Treatment and the Risk of Long-Term Cardiovascular Morbidity and Mortality in Thyroid Cancer Patients: A Nationwide Cohort Study
by: Chun-Hao Kao, et al.
Published: (2021-09-01)

Comparison of Thyroglobulin Measurements Using Three Different Immunoassay Kits: A BRAMHS Tg-Plus RIA Kit, a BRAMHS hTg Sensitive Kryptor Kit, and a Beckman Coulter ACCESS Immunoassay Kit
by: Mijin Kim, et al.
Published: (2016-09-01)

Radioiodine therapy in skeletal metastases from well-differentiated thyroid cancer: a Johannesburg experience
by: Nalini Sindy Perumal, et al.
Published: (2010-03-01)

The impact of minimal extrathyroidal extension in the recurrence of papillary thyroid cancer patients
by: Maria Fernanda Ozorio de Almeida, et al.
Published: (2020-06-01)

Cervical lymphatic malformation demonstrating thyroglobulin on fine needle aspirate washout
by: Ashwin Agnihotri, et al.
Published: (2020-12-01)

Progressive evolution of thyroid adenoma to thyroid carcinoma
by: Aisyah Elliyanti
Published: (2019-09-01)

Urinary iodine excretion after using povidone iodine or chlorhexidine gluconate for topical disinfectant in patients undergoing thyroidectomy due to thyroid carcinoma: When to do radio active iodine therapy?
by: Soheila Shokrollahi Yancheshmeh, et al.
Published: (2023-01-01)

Oncocytic Papillary Thyroid Carcinoma and Oncocytic Poorly Differentiated Thyroid Carcinoma: Clinical Features, Uptake, and Response to Radioactive Iodine Therapy, and Outcome
by: Jelena Lukovic, et al.
Published: (2021-12-01)

Preablative Stimulated Thyroglobulin and Thyroglobulin Reduction Index as Decision-Making Markers for Second Radioactive Iodine Therapy in Patients with Structural Incomplete Response
by: Wang L, et al.
Published: (2021-07-01)

Thyroglobulin as an evolving biomarker of iodine reserve in thyroid dysfunction assessment in pregnancy
by: Terry Terfa Gbaa
Published: (2022-01-01)

The utility of low-iodine diet in preparation for thyroid cancer therapy with radioactive iodine—A cohort study
by: Hongxiu Luo, et al.
Published: (2022-09-01)

A Role for Iodide and Thyroglobulin in Modulating the Function of Human Immune Cells
by: Mahmood Y. Bilal, et al.
Published: (2017-11-01)